SC

Saras Capital

Europe, Kent, United Kingdom, Canterbury

Description

Saras Capital is an a investment firm.

Investor Profile

Saras Capital has backed more than 5 startups, with 2 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series C rounds (top funding stages).
  • Majority of deals are located in United Kingdom, France, United States.
  • Strong thematic focus on Biotechnology, Bioinformatics, Genetics.

Stage Focus

  • Seed (80%)
  • Series C (20%)

Country Focus

  • United Kingdom (40%)
  • France (40%)
  • United States (20%)

Industry Focus

  • Biotechnology
  • Bioinformatics
  • Genetics
  • Life Science
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Saras Capital frequently co-invest with?

CA
Europe, Madrid, Spain, Madrid
Co-Investments: 1
Marshall Wace
Europe, England, United Kingdom, London
Co-Investments: 1
Sahsen Ventures
North America, Washington, United States, Seattle
Co-Investments: 1
Cancer Research Horizons
Europe, England, United Kingdom, London
Co-Investments: 1
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Kindred Capital
Europe, England, United Kingdom, London
Co-Investments: 1
S
Europe, England, United Kingdom, London
Co-Investments: 2
Cancer Research Institute
North America, New York, United States, New York
Co-Investments: 1
Bioeconomy Capital
North America, Washington, United States, Seattle
Co-Investments: 1
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 1

Which angels does Saras Capital often collaborate with?

NS
Europe, England, United Kingdom, London
Shared Deals: 1
KM
North America, Kentucky, United States, London
Shared Deals: 1
SB
North America, California, United States, San Francisco
Shared Deals: 1
DH
Europe, England, United Kingdom, London
Shared Deals: 1
AR
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Saras Capital?

Cellbyte

München, Bayern, Germany

Cellbyte is an AI based firm that offers safety and security standards for pharma companies to provide life-changing treatments to patients.

Artificial Intelligence (AI)Health CarePharmaceutical
SeedNov 18, 2025
Amount Raised: $2,750,000
Modulight Bio

Boston, Massachusetts, United States

Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders.

BiotechnologyHealth CareMedicalTherapeutics
SeedNov 13, 2025
Amount Raised: $12,000,000
Valink Therapeutics

London, England, United Kingdom

Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.

Health CareTherapeuticsWellness
SeedOct 20, 2025
Amount Raised: $11,800,000
Aerska

Dublin, Dublin, Ireland

Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain disorders.

Biotechnology
SeedOct 1, 2025
Amount Raised: $21,000,000
Kyron.bio

Faubourg Saint-jacques, Bourgogne, France

Kyron.bio uses the power of glycan alterations to enable improved protein therapies.

Biotechnology
SeedMay 28, 2025
Amount Raised: $6,211,334
Generare

Paris, Ile-de-France, France

Generare is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria.

Biotechnology
SeedOct 7, 2024
Amount Raised: $5,487,149
Infinitopes

Oxford, Oxfordshire, United Kingdom

Infinitopes is developer of vaccines for the treatment of cancer.

Biotechnology
SeedApr 30, 2024
Amount Raised: $15,985,813
Parse Biosciences

Seattle, Washington, United States

Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.

BioinformaticsBiotechnologyGeneticsLife Science
Series CDec 14, 2023
Amount Raised: $50,000,000
Eden Bio

London, England, United Kingdom

Harnessing nature's potential

BioinformaticsBiotechnologyMachine Learning
SeedNov 14, 2022
Amount Raised: $1,175,206